1
|
Familial Mediterranean Fever and Multiple Sclerosis Successfully Treated With Interferon Beta-1a: A Case Report. Arch Rheumatol 2019; 34:443-446. [PMID: 32010894 DOI: 10.5606/archrheumatol.2019.7249] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2018] [Accepted: 01/23/2019] [Indexed: 01/29/2023] Open
Abstract
Multiple sclerosis (MS) is the most common demyelinating disease in Turkey while familial Mediterranean fever (FMF) is the most common periodic fever syndrome worldwide. In this article, we report a 37-year-old male patient admitted with complaint of difficulty in walking. He had been taking colchicine at admission for 27 years. Despite this therapy, he had been experiencing twice monthly severe FMF attacks. After systemic and neurological examinations, laboratory tests and cranial and spinal magnetic resonance imaging, he was diagnosed as MS. Interferon (IFN) beta-1a was initiated three times/weekly subcutaneously for MS treatment. He stopped colchicine treatment after five months of IFN treatment because he did not suffer from any FMF attacks. He is still attack free for both diseases for a follow-up duration of 12 months. IFN beta is one of the most preferred agents for MS treatment but not one of the agents used for the treatment of FMF. Interferon beta can be a treatment of choice in patients with coincident FMF and MS and can be used in colchicine-resistant patients after being studied in systematic clinical studies.
Collapse
|
2
|
Arakelov G, Arakelov V, Nazaryan K. Complex formation dynamics of native and mutated pyrin's B30.2 domain with caspase-1. Proteins 2018; 86:676-683. [DOI: 10.1002/prot.25494] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Revised: 03/05/2018] [Accepted: 03/15/2018] [Indexed: 11/10/2022]
Affiliation(s)
- Grigor Arakelov
- Russian-Armenian University; Yerevan 0051 Armenia
- Laboratory of Computation Modeling of Biological Processes; Institute of Molecular Biology, National Academy of Sciences of the Republic of Armenia; Yerevan 0014 Armenia
| | | | - Karen Nazaryan
- Russian-Armenian University; Yerevan 0051 Armenia
- Laboratory of Computation Modeling of Biological Processes; Institute of Molecular Biology, National Academy of Sciences of the Republic of Armenia; Yerevan 0014 Armenia
| |
Collapse
|
3
|
Erdem GC, Erdemir S, Abaci I, Aydin AKK, Everest E, Turanli ET. Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture models. Genet Mol Biol 2017; 40:688-697. [PMID: 28863210 PMCID: PMC5596369 DOI: 10.1590/1678-4685-gmb-2016-0234] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2016] [Accepted: 03/02/2017] [Indexed: 12/25/2022] Open
Abstract
The function of gene body DNA methylation in alternative splicing, and its relation to disease pathogenesis is not fully elucidated. The gene for familial Mediterranean fever (MEFV) encodes the pyrin protein and contains a 998 bp CpG island, covering the second exon, which is differentially methylated in FMF patients compared to healthy controls. Our further observation of increased exon 2-spliced MEFV transcript in leukocytes of FMF patients provoked us to test the role of exon methylation in alternative splicing using inflammatory cell culture models. First, in vitro exon methylation triggered an increased level of exon 2 exclusion using a splicing cassette in a promyelocytic leukemia cell line (HL-60). HL-60 cells subjected to methylating and demethylating agents, as well as cells differentiated to neutrophil-like cells, exhibited different levels of spliced/unspliced transcripts. We observed increased levels of spliced transcripts in neutrophil-like (p = 0.0005), activated (p = 0.0034) and methylated cells (p < 0.0001), whereas decreased levels in demethylated cells (p = 0.0126) compared to control untreated HL-60 cells. We also showed that the protein isoform of pyrin lacking the exon 2 has an adverse subcellular localization in neutrophil-like cells. Therefore, it remains in the cytoplasm rather than the nucleus. This may point to an epigenetic involvement in an important inflammatory gene.
Collapse
Affiliation(s)
- Gokce Celikyapi Erdem
- Department of Molecular Biology Genetics and Biotechnology, Dr. Orhan Ocalgiray Molecular Biology and Genetics Research Centre, Graduate School of Science, Engineering and Technology, Istanbul Technical University, Istanbul, Turkey
| | - Sule Erdemir
- Department of Molecular Biology Genetics and Biotechnology, Dr. Orhan Ocalgiray Molecular Biology and Genetics Research Centre, Graduate School of Science, Engineering and Technology, Istanbul Technical University, Istanbul, Turkey
| | - Irem Abaci
- Department of Molecular Biology Genetics and Biotechnology, Dr. Orhan Ocalgiray Molecular Biology and Genetics Research Centre, Graduate School of Science, Engineering and Technology, Istanbul Technical University, Istanbul, Turkey
| | - Asli K Kirectepe Aydin
- Department of Molecular Biology Genetics and Biotechnology, Dr. Orhan Ocalgiray Molecular Biology and Genetics Research Centre, Graduate School of Science, Engineering and Technology, Istanbul Technical University, Istanbul, Turkey
| | - Elif Everest
- Department of Molecular Biology Genetics and Biotechnology, Dr. Orhan Ocalgiray Molecular Biology and Genetics Research Centre, Graduate School of Science, Engineering and Technology, Istanbul Technical University, Istanbul, Turkey
| | - Eda Tahir Turanli
- Department of Molecular Biology Genetics and Biotechnology, Dr. Orhan Ocalgiray Molecular Biology and Genetics Research Centre, Graduate School of Science, Engineering and Technology, Istanbul Technical University, Istanbul, Turkey.,Molecular Biology and Genetics Department, Faculty of Science and Letters, Istanbul Technical University, Istanbul, Turkey
| |
Collapse
|
4
|
Neocleous V, Costi C, Kyriakou C, Kyriakides TC, Shammas C, Skordis N, Toumba M, Kyriakou S, Koliou M, Kousparou M, Onoufriou M, Hadjipanayis A, Iasonides M, Atamyan VN, Pierides A, Christophidou-Anastasiadou V, Tanteles GA, Phylactou LA. Familial Mediterranean Fever Associated withMEFVMutations in a Large Cohort of Cypriot Patients. Ann Hum Genet 2014; 79:20-7. [DOI: 10.1111/ahg.12087] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Accepted: 09/02/2014] [Indexed: 11/29/2022]
Affiliation(s)
- Vassos Neocleous
- Department of Molecular Genetics; Function and Therapy; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| | - Constantina Costi
- Department of Molecular Genetics; Function and Therapy; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| | - Christina Kyriakou
- Department of Molecular Genetics; Function and Therapy; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| | | | - Christos Shammas
- Department of Molecular Genetics; Function and Therapy; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| | - Nicos Skordis
- Department of Pediatrics; Hospital ‘Archbishop Makarios III ’; Nicosia Cyprus
- St. George's, University of London; University of Nicosia Medical School; Nicosia Cyprus
| | | | - Sophia Kyriakou
- Department of Economics; University of Cyprus; Nicosia Cyprus
| | - Maria Koliou
- Department of Pediatrics; Hospital ‘Archbishop Makarios III ’; Nicosia Cyprus
| | - Marianna Kousparou
- Department of Pediatrics; Hospital ‘Archbishop Makarios III ’; Nicosia Cyprus
| | - Margarita Onoufriou
- Department of Pediatrics; Hospital ‘Archbishop Makarios III ’; Nicosia Cyprus
| | - Adamos Hadjipanayis
- Department of Pediatrics; Larnaca General Hospital; Larnaca Cyprus
- The School of Medicine; European University of Cyprus; Egkomi Cyprus
| | | | - Vick N Atamyan
- Corner Limassol Av. & Armenias Str., Acropolis; Nicosia Cyprus
| | - Alkis Pierides
- Department of Nephrology; Hippocrateon Hospital; Nicosia Cyprus
| | - Violetta Christophidou-Anastasiadou
- Department of Pediatrics; Hospital ‘Archbishop Makarios III ’; Nicosia Cyprus
- Department of Clinical Genetics; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| | - George A Tanteles
- Department of Clinical Genetics; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| | - Leonidas A Phylactou
- Department of Molecular Genetics; Function and Therapy; The Cyprus Institute of Neurology and Genetics; Nicosia Cyprus
| |
Collapse
|
5
|
Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, De Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn ME, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 2012; 71:1599-605. [PMID: 22661645 PMCID: PMC3500529 DOI: 10.1136/annrheumdis-2011-201271] [Citation(s) in RCA: 119] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Hereditary recurrent fevers (HRFs) are a group of monogenic autoinflammatory diseases characterised by recurrent bouts of fever and serosal inflammation that are caused by pathogenic variants in genes important for the regulation of innate immunity. Discovery of the molecular defects responsible for these diseases has initiated genetic diagnostics in many countries around the world, including the Middle East, Europe, USA, Japan and Australia. However, diverse testing methods and reporting practices are employed and there is a clear need for consensus guidelines for HRF genetic testing. Draft guidelines were prepared based on current practice deduced from previous HRF external quality assurance schemes and data from the literature. The draft document was disseminated through the European Molecular Genetics Quality Network for broader consultation and amendment. A workshop was held in Bruges (Belgium) on 18 and 19 September 2011 to ratify the draft and obtain a final consensus document. An agreed set of best practice guidelines was proposed for genetic diagnostic testing of HRFs, for reporting the genetic results and for defining their clinical significance.
Collapse
Affiliation(s)
- Y Shinar
- Unité médicale des maladies autoinflammatoires, CHRU Montpellier, INSERM U844, Université UM1, Montpellier, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Kirectepe AK, Kasapcopur O, Arisoy N, Celikyapi Erdem G, Hatemi G, Ozdogan H, Tahir Turanli E. Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever. BMC MEDICAL GENETICS 2011; 12:105. [PMID: 21819621 PMCID: PMC3175150 DOI: 10.1186/1471-2350-12-105] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/01/2010] [Accepted: 08/07/2011] [Indexed: 01/15/2023]
Abstract
BACKGROUND MEFV mutations and decreased expression level of the gene are related to FMF pathology. DNA methylation at CpG islands is a well-known mechanism for transcriptional silencing. MEFV has a CpG island, spanning a part of the first intron and the whole of the second exon of the gene covering 998 bp region. Here, we tested the hypothesis that the MEFV transcript level in FMF patients correlates with its methylation level, and methylation, by allowing transcription silencing, has a role in FMF ethiopathogenesis. METHODS The study group was composed of pediatric FMF patients (N = 51) and age-gender matched healthy controls (N = 21). The relative expression level of MEFV was assessed via quantitative real-time PCR (qRT-PCR) and bisulfite sequencing (BS) was performed to analyse the methylation level quantitatively. RESULTS MEFV expression in FMF patients were decreased compared to healthy controls (P = 0.031). Methylation level of exon 2 of MEFV was found to be slightly higher in FMF patients compared to healthy controls (76% versus 74%) (P = 0.049). The expression level of the MEFV was negatively correlated with the methylation level of the CpG island in both FMF and healthy controls groups (cor = -0.29, P = 0.041) but more so in the FMF only group (cor = -0.36, P = 0.035). CONCLUSIONS In this study, the relation between reduced MEFV expression level and FMF was confirmed. Observed slight increase in methylation in FMF patients, and correlation of methylation with expression might be indicative of its role in FMF, however a larger dataset is needed to confirm our preliminary findings.
Collapse
Affiliation(s)
- Asli K Kirectepe
- Institute of Science and Technology, Molecular Biology Genetics and Biotechnology Graduate Program, Istanbul Technical University, Istanbul, Turkey
| | - Ozgur Kasapcopur
- Cerrahpasa Medical Faculty, Department of Pediatric Rheumatology, Istanbul University, Istanbul, Turkey
| | - Nil Arisoy
- Cerrahpasa Medical Faculty, Department of Pediatric Rheumatology, Istanbul University, Istanbul, Turkey
| | - Gokce Celikyapi Erdem
- Institute of Science and Technology, Molecular Biology Genetics and Biotechnology Graduate Program, Istanbul Technical University, Istanbul, Turkey
| | - Gulen Hatemi
- Cerrahpasa Medical Faculty, Department of Rheumatology, Istanbul University, Istanbul, Turkey
| | - Huri Ozdogan
- Cerrahpasa Medical Faculty, Department of Rheumatology, Istanbul University, Istanbul, Turkey
| | - Eda Tahir Turanli
- Institute of Science and Technology, Molecular Biology Genetics and Biotechnology Graduate Program, Istanbul Technical University, Istanbul, Turkey
- Faculty of Science and Letters, Department of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey
| |
Collapse
|
7
|
The regulation of MEFV expression and its role in health and familial Mediterranean fever. Genes Immun 2011; 12:497-503. [DOI: 10.1038/gene.2011.53] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
8
|
Kirectepe AK, Erdem GC, Senturk N, Arisoy N, Hatemi G, Ozdogan H, Kasapcopur O, Tahir Turanli E. Increased expression of exon 2 deleted MEFV transcript in familial Mediterranean fever patients. Int J Immunogenet 2011; 38:327-9. [PMID: 21615705 DOI: 10.1111/j.1744-313x.2011.01015.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
A defect in MEFV gene expression regulation has been implicated in familial Mediterranean fever (FMF) etiopathophysiology. Here we show significantly higher expression level in second exon lacking MEFV transcript in FMF patients compared with healthy controls (P=0.026). Our results also point out a possible role of exon 2 deleted MEFV transcript in FMF pathogenesis.
Collapse
Affiliation(s)
- A K Kirectepe
- Molecular Biology Genetics and Biotechnology Graduate Program, Institute of Science and Technology, Istanbul Technical University, Istanbul, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Aslan D. Familial Mediterranean fever with a single MEFV mutation: can a deletion resulting in α-thalassemia be the cause? J Hum Genet 2010; 56:169-71. [PMID: 21179105 DOI: 10.1038/jhg.2010.160] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|